Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Apligraf skin construct speeds healing of diabetic foot ulcers

Aug. 31, 1999

Ortec requests FDA permission to initiate CCS trial for diabetic ulcer therapy

Aug. 31, 1999

Yoshitomi discloses cytokine production inhibitors for treating and preventing allergic reactions

Aug. 25, 1999

FDA expands HUD designation for Ortec's Composite Cultured Skin

Aug. 25, 1999

Two new RAR antagonists emerge from retinoid research program at Bristol-Myers Squibb

Aug. 24, 1999

QLT begins phase II trial for psoriasis treatment

Aug. 24, 1999

L'Oreal compounds prevent skin aging in experimental models

Aug. 23, 1999

Zenyaku Kogyo will develop and market novel psoriasis treatment in Japan

Aug. 20, 1999

Gliatech's IDE for ADCON-L approved by FDA

Aug. 20, 1999

IL-8 antagonists with broad therapeutic potential synthesized at SmithKline Beecham

Aug. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...